Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease

There are no proven, effective therapies for polycystic kidney disease (PKD) or polycystic liver disease (PLD). We enrolled 42 patients with severe PLD resulting from autosomal dominant PKD (ADPKD) or autosomal dominant PLD (ADPLD) in a randomized, double-blind, placebo-controlled trial of octreotid...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hogan, Marie C., Masyuk, Tetyana V., Page, Linda J., Kubly, Vickie J., Bergstralh, Eric J., Li, Xujian, Kim, Bohyun, King, Bernard F., Glockner, James, Holmes, David R., Rossetti, Sandro, Harris, Peter C., LaRusso, Nicholas F., Torres, Vicente E.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Nephrology 2010
Assuntos:
Clinical Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2900957/
https://ncbi.nlm.nih.gov/pubmed/20431041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2009121291
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares